Publications

Kidney Publications

  • Katz-Brull R, Rofsky NM, Morrin MM, Pedrosa I, George DJ, Michaelson MD, Marquis RP, Maril M, Noguera C, Lenkinski RE. Decreases in free cholesterol and fatty acid unsaturation in renal cell carcinoma demonstrated by breath-hold magnetic resonance spectroscopy. Am J Physiol Renal Physiol. 2005 Apr;288(4):F637-41. PMID: 15572523.
  • Adey GS, Pedrosa I, Rofsky NM, Sanda MG, DeWolf WC. Lower limits of detection using magnetic resonance imaging for solid components in cystic renal neoplasms. Urology. 2008 Jan;71(1):47-51. PMID: 18242363.
  • Pedrosa I, Chou MT, Ngo L, H Baroni R, Genega EM, Galaburda L, DeWolf WC, Rofsky NM. MR classification of renal masses with pathologic correlation. Eur Radiol. 2008 Feb;18(2):365-75. Epub 2007 Sep 26. PMID: 17899106.
  • de Bazelaire C, Alsop DC, George D, Pedrosa I, Wang Y, Michaelson MD, Rofsky NM. MRI measured tumor blood flow change following antiangiogenic therapy with PTK787/ZK 222584 correlates with clinical outcome in metastatic renal cell carcinoma. Clin Cancer Res. 2008 Sep 1;14(17):5548-54. PMID: 18765547.
  • Sun MR, Ngo L, Genega EM, Atkins MB, Finn ME, Rofsky NM, Pedrosa I. Renal Cell Carcinoma: Dynamic Contrastenhanced MR Imaging for Differentiation of Tumor Subtypes--Correlation with Pathologic Findings. Radiology. 2009 Mar;250(3):793-802. PMID: 19244046.
  • Robson PM, Madhuranthakam AJ, Dai W, Pedrosa I, Rofsky NM, Alsop DC. Strategies for reducing respiratory motion artifacts in renal perfusion imaging with arterial spin labeling. Magn Reson Med. 2009 Jun;61(6):1374-87 PMID: 19319891.
  • Schor-Bardach R, Alsop D, Pedrosa I, Solazzo SA, Atkins BA, Regan M, Signoretti S, Lenkinski RE, Goldberg SN. Does arterial spin labeling MRI measured tumor perfusion correlate with response of renal cell cancer to antiangiogenic therapy in a mouse model? Radiology. 2009 Jun;251(3):731-42. PMID: 19474376.
  • Sena BF, Stern J, Pandharipande P, Klemm B, Bulman J, Pedrosa I, Rofsky NM. Screening Patients to Assess Renal Function Prior to Administering Gadolinium Chelates: Assessment of The Choyke Questionnaire. AJR Am J Roentgenol. 2010 Aug;195(2):424-8. PMID: 20651199.
  • Krajewski K, Guo M, Van den Abbeele AD, Yap J, Ramaiya N, Jagannathan J, Heng DYC, Atkins MB, McDermott DF, Schutz FAB, Pedrosa I, Choueiri TK. Comparison of Four, Early, Posttherapy Imaging Changes (EPTIC) (RECIST 1.0, Tumor Shrinkage, Computed Tomography Tumor Density, and Choi Criteria) in Assessing Outcome to Vascular Endothelial Growth Factor-Targeted Therapy in Patients with Advanced Renal Cell Carcinoma. Eur Urol. 2011 May;59(5):856-62. PMID: 21306819.
  • Dabydeen DA, Jagannathan JP, Ramaiya N, Krajewski K, Schutz FA, Cho DC, Pedrosa I, Choueiri TK. Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: Incidence, radiographic findings and correlation with clinical outcome. Eur J Cancer. 2012 Jul;48(10):1519-24. PMID: 22483544.
  • Rosenkrantz AB, Sekhar A, Genega EM, Melamed J, Babb JS, Patel AD, Lo A, Najarian RM, Ahmed M, Pedrosa I. Prognostic Implications of the Magnetic Resonance Imaging Appearance in Papillary Renal Cell Carcinoma. Eur Radiol. 2013 Feb;23(2):579-87. Epub 2012 Aug 21. PMID: 22903703.
  • Torres VE, Chapman AB, Perrone RD, Bae KT, Abebe KZ, Bost JE, Miskulin DC, Steinman TI, Braun WE, Winklhofer FT, Hogan MC, Oskoui FR, Kelleher C, Masoumi A, Glockner J, Halin NJ, Martin DR, Remer E, Patel N, Pedrosa I, Wetzel LH, Thompson PA, Miller JP, Meyers CM, Schrier RW; HALT PKD Study Group. Analysis of baseline parameters in the HALT polycystic kidney disease trials. Kidney Int. 2012 Mar;81(6):577-85. Epub 2011 Dec 28. PMID: 22205355.
  • Hindman N, Ngo L, Genega EM, Melamed J, Wei J, Braza JM, Rofsky NM, Pedrosa I. Angiomyolipoma with Minimal Fat: Can It Be Differentiated from Clear Cell Renal Cell Carcinoma by Using Standard MR Techniques? Radiology. 2012 Nov;265(2):468-77. PMID: 23012463.
  • Pedrosa I, Rafatzand K, Robson P, Wagner AA, Atkins MB, Rofsky NM, Alsop DC. Arterial spin labeling MR imaging for characterisation of renal masses in patients with impaired renal function: initial experience. Eur Radiol. 2012 Feb;22(2):484-92. PMID: 21877173.
  • Lanzman RS, Robson PM, Sun MR, Patel AD, Mentore K, Wagner AA, Genega EM, Rofsky NM, Alsop DC, Pedrosa I. Arterial Spin-labeling MR Imaging of Renal Masses: Correlation with Histopathologic Findings. Radiology. 2012 Dec;265(3):799-808. PMID: 23047841.
  • Yassin A, Pedrosa I, Genega E, Rofsky NM, Lenkinski RE. In vitro MR Imaging of Renal Stones With An Ultra-Short Echo Time Magnetic Resonance Imaging Sequence. Acad Radiol. 2012 Dec;19(12):1566-72. PMID: 22959582.
  • Beddy P, Genega EM, Ngo L, Hindman N, Wei J, Bullock A, Bhatt RS, Atkins MA, Pedrosa I. Tumor Necrosis on Magnetic Resonance Imaging Correlates with Aggressive Histology and Disease Progression in Clear Cell Renal Cell Carcinoma. Clin Genitourin Cancer. 2014 Feb;12(1):55-62. Epub 2013 Oct 19. PMID: 24145001.
  • Wanga SS, Gua YF, Wolff N, Stefaniusa K, Christiec A, Deyd A, Xiec XJ, Pedrosa I, Carroll T, Payal Kapur P, McKay RM, Brugarolas J. Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis. Proc Natl Acad Sci USA. 2014 Nov 18;111(46):16538-43. doi: 10.1073/pnas.1414789111. Epub 2014 Oct 30. PMID: 25359211. PMCID: PMC4246264.
  • Campbell N, Rosenkrantz AB, Pedrosa I. MRI Phenotype in Renal Cancer: Is It Clinically Relevant? Top Magn Reson Imaging. 2014 Apr;23(2):95-115. PMID: 24690616. PMCID:4484274
  • Schrier RW, Abebe KZ, Perrone RD, Torres VE, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, HoganMC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, Bae KT, Moore CG, Chapman AB; HALT-PKDTrial Investigators. Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med. 2014 Dec11;371(24):2255-66. Epub 2014 Nov 15. PMID: 25399733. PMCID: PMC4343258.
  • Torres VE, Abebe KZ, Chapman AB, Schrier RW, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, Moore CG, Perrone RD; HALT-PKD Trial nvestigators. Angiotensin blockade in late autosomal dominant polycystic kidney disease. N Engl J Med. 2014 Dec 11;371(24):2267-76. Epub 2014 Nov 15. PMID: 25399731. PMCID: PMC4284824.
  • Hannan R, Margulis V, Chun SG, Cannon N, Kim N, Abdulrahman RE, Sagalowsky A, Pedrosa I, Choy H, Brugarolas JB, Timmerman RD. Stereotactic Radiation Therapy of Renal Cancer Inferior Vena Cava Tumor Thrombus. Cancer Biol Ther. 2015 Mar 24:0. [Epub ahead of print]. PMID: 25800036
  • Durinck S, Stawiski EW, Pavía-Jiménez A, Modrusan Z, Kapur P, Jaiswal BS, Zhang N, Toffessi-Tcheuyap V, Nguyen TT, Pahuja KB, Chen YJ, Saleem S, Chaudhuri S, Heldens S, Jackson M, Peña-Llopis S, Guillory J, Toy K, Ha C, Harris CJ, Holloman E, Hill HM, Stinson J, Sanchez Rivers C, Janakiraman V, Wang W, Kinch LN, Grishin NV, Haverty PM, Chow B, Gehring JS, Reeder J, Pau G, Wu TD, Margulis V, Lotan Y, Sagalowsky A, Pedrosa I, de Sauvage FJ, Brugarolas J, and Seshagiri S. Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes. Nat Genet. 2015 Jan;47(1):13-21. PMID: 25401301. PMCID4489427
  • Staub D, Hannan R, Thomas K, Jiang S, Pedrosa I, Kapur P, Brugarolas J, Wang J. TU-AB-BRA-02: Predicting Gene Mutations in Renal Cell Carcinoma Using Machine Learning. Med Phys. 2015 Jun;42(6):3586.
  • Robson PM, Madhuranthakam AJ, Smith MP, Sun MR, Dai W, Rofsky NM, Pedrosa I, Alsop DC. Volumetric Arterial Spinlabeled Perfusion Imaging of the Kidneys with a Three-dimensional Fast Spin Echo Acquisition. Acad Radiol. 2016 Feb;23(2):144-54. Epub 2015 Oct 29. PMID: 26521186.
  • Sun MR, Brook A, Powell MF, Kaliannan K, Wagner AA, Kaplan ID, Pedrosa I. Effect of Stereotactic Body Radiotherapy on the Growth Kinetics and Enhancement Pattern of Primary Renal Tumors. AJR Am J Roentgenol. 2016 Mar;206(3):544-53. PMID: 26901010.
  • Zhang Y, Kapur P, Yuan Q, Xi Y, Carvo I, Signoretti S, Dimitrov I, Cadeddu JA, Margulis V, Muradyan N, Brugarolas J, Madhuranthakam AJ, Pedrosa I. Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments. Clin Genitourin Cancer. 2016 Feb;14(1):e25-36. Epub 2015 Aug 29. PMID: 26422014. PMCID: PMC4698181.
  • Diaz de Leon A, Costa D, Pedrosa I. Role of Multiparametric MR Imaging in Malignancies of the Urogenital Tract. Magn Reson Imaging Clin N Am. 2016 Feb;24(1):187-204. PMID: 26613881.
  • Yokoo T, Clark HR, Pedrosa I, Yuan Q, Dimitrov I, Zhang Y, Lingvay I, Beg MS, Bobulescu IA. Quantification of Renal Steatosis in Type II Diabetes Mellitus using Dixon-Based MRI. J Magn Reson Imaging. 2016 Nov;44(5):1312-1319. Epub 2016 Mar 23. PMID: 27007212.
  • Yuan Q, Kapur P, Zhang Y, Xi Y, Carvo I, Signoretti S, Dimitrov IE, Cadeddu JA, Margulis V, Brugarolas J, Madhuranthakam AJ, Pedrosa I. Intratumor Heterogeneity of Perfusion and Diffusion in Clear-Cell Renal Cell Carcinoma: Correlation with Tumor Cellularity. Clin Genitourin Cancer. 2016 Dec;14(6):e585-e594. Epub 2016 Apr 22. PMID: 27209349.
  • Chen W, Hill H, Christie A, Kim MS, Holloman E, Pavía-Jiménez A, Homayoun F, Ma Y, Patel N, Yell P, Hao G, Yousuf Q, Joyce A, Pedrosa I, Geiger H, Zhang H, Chang J, Gardner KH, Bruick RK, Reeves C, Hwang TH, Courtney K, Frenkel E, Sun X, Zojwalla N, Wong T, Rizzi JP, Wallace EM, Josey JA, Xie Y, Xie XJ, Kapur P, McKay RM, Brugarolas J. Targeting Renal Cell Carcinoma with a HIF-2 Antagonist. Nature. 2016 Sep 5;539(7627):112-117. [Epub ahead of print]. PMID: 27595394.